Aims: The usefulness of estrogen replacement therapy (ERT) in preventing oxidative stress associated with menopause is controversial. We aimed to study if there is a critical time window for effective treatment of the effects of ovariectomy with estrogens at the molecular, metabolic, and cellular level. Results: Our main finding is that early, but not late onset of ERT prevents an ovariectomy-associated increase in mitochondrial hydrogen peroxide levels, oxidative damage to lipids and proteins, and a decrease in glutathione peroxidase and catalase activity in rats. This may be due to a change in the estrogen receptor (ER) expression profile: ovariectomy increases the ER α/β ratio and immediate estrogen replacement prevents it. Positron emission tomography analysis shows that ovariectomy decreases the brain glucose uptake in vivo and that estrogen administration is beneficial, but only if administered immediately after deprivation. Ovariectomy decreases GLUT-1 and 3 glucose transporters in the brain, and only early onset estrogen administration prevents it. Plasma from rats treated with estrogens immediately after ovariectomy show similar metabolomics profiles as controls. Innovation: We provide molecular basis for the recommendation of early onset ERT and explain its lack of effectiveness if a significant time period elapses after ovariectomy and probably after the onset of menopause. Conclusion: Only early, but not late onset administration of estrogens after ovariectomy has beneficial effects at molecular levels on oxidative stress, brain glucose uptake, and metabolomic profiles. Antioxid. Redox Signal. 20, 236–246.
Get full access to this article
View all access options for this article.
References
1.
Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial. JAMA, 273: 199–208, 1995.
2.
AebiH. Catalase in vitro. Methods Enzymol, 105: 121–126, 1984.
3.
Afanas'evI. Signaling and damaging functions of free radicals in aging-free radical theory, hormesis, and TOR. Aging Dis, 1: 75–88, 2010.
4.
AllisonMA, MansonJE, LangerRD, CarrJJ, RossouwJE, PettingerMB, PhillipsL, CochraneBB, EatonCB, GreenlandP, HendrixS, HsiaJ, HuntJR, JacksonRD, JohnsonKC, KullerLH, and RobinsonJ. Oophorectomy, hormone therapy, and subclinical coronary artery disease in women with hysterectomy: the Women's Health Initiative coronary artery calcium study. Menopause, 15: 639–647, 2008.
5.
ArnalJF, ClamensS, PechetC, Negre-SalvayreA, AlleraC, GirolamiJP, SalvayreR, and BayardF. Ethinylestradiol does not enhance the expression of nitric oxide synthase in bovine endothelial cells but increases the release of bioactive nitric oxide by inhibiting superoxide anion production. Proc Natl Acad Sci U S A, 93: 4108–4113, 1996.
6.
Barja de QuirogaC. Mitochondrial oxygen radical generation and leak: sites of produccion in states 4 an 3, organ spedificity and relation to aging and longevity. J Bioenerg Biomembr, 31: 347–366, 1999.
7.
BarjaG. Mitochondrial free radical production and aging in mammals and birds. Ann N Y Acad Sci, 854: 224–238, 1998.
8.
BarjaG and HerreroA. Oxidative damage to mitochondrial DNA is inversely related to maximum life span in the heart and brain of mammals. FASEB J, 14: 312–318, 2000.
9.
BorrasC, GambiniJ, Gomez-CabreraMC, SastreJ, PallardoFV, MannGE, and VinaJ. 17beta-oestradiol up-regulates longevity-related, antioxidant enzyme expression via the ERK1 and ERK2[MAPK]/NFkappaB cascade. Aging Cell, 4: 113–118, 2005.
10.
BorrasC, GambiniJ, Lopez-GruesoR, PallardoFV, and VinaJ. Direct antioxidant and protective effect of estradiol on isolated mitochondria. Biochim Biophys Acta, 1802: 205–211, 2010.
11.
BorrasC, GambiniJ, and VinaJ. Mitochondrial oxidant generation is involved in determining why females live longer than males. Front Biosci, 12: 1008–1013, 2007.
12.
BorrasC, SastreJ, Garcia-SalaD, LloretA, PallardoFV, and VinaJ. Mitochondria from females exhibit higher antioxidant gene expression and lower oxidative damage than males. Free Radic Biol Med, 34: 546–552, 2003.
13.
CameronVA, AutelitanoDJ, EvansJJ, EllmersLJ, EspinerEA, NichollsMG, and RichardsAM. Adrenomedullin expression in rat uterus is correlated with plasma estradiol. Am J Physiol Endocrinol Metab, 282: E139–E146, 2002.
14.
DarlingGM, JohnsJA, McCloudPI, and DavisSR. Estrogen and progestin compared with simvastatin for hypercholesterolemia in postmenopausal women. N Engl J Med, 337: 595–601, 1997.
15.
EnserinkM. Women's health. The vanishing promises of hormone replacement. Science, 297: 325–326, 2002.
16.
FloheL and GunzlerWA. Assays of glutathione peroxidase. Methods Enzymol, 105: 114–121, 1984.
17.
FuegerBJ, CzerninJ, HildebrandtI, TranC, HalpernBS, StoutD, PhelpsME, and WeberWA. Impact of animal handling on the results of 18F-FDG PET studies in mice. J Nucl Med, 47: 999–1006, 2006.
18.
GradyD, RubinSM, PetittiDB, FoxCS, BlackD, EttingerB, ErnsterVL, and CummingsSR. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med, 117: 1016–1037, 1992.
19.
GruberCJ, TschugguelW, SchneebergerC, and HuberJC. Production and actions of estrogens. N Engl J Med, 346: 340–352, 2002.
20.
HamacherK, CoenenHH, and StocklinG. Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med, 27: 235–238, 1986.
21.
HekimiS, LapointeJ, and WenY. Taking a “good” look at free radicals in the aging process. Trends Cell Biol, 21: 569–576, 2011.
22.
HerringtonDM, WerbelBL, RileyWA, PusserBE, and MorganTM. Individual and combined effects of estrogen/progestin therapy and lovastatin on lipids and flow-mediated vasodilation in postmenopausal women with coronary artery disease. J Am Coll Cardiol, 33: 2030–2037, 1999.
23.
HulleyS, GradyD, BushT, FurbergC, HerringtonD, RiggsB, and VittinghoffE. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA, 280: 605–613, 1998.
24.
IrwinRW, YaoJ, HamiltonRT, CadenasE, BrintonRD, and NilsenJ. Progesterone and estrogen regulate oxidative metabolism in brain mitochondria. Endocrinology, 149: 3167–3175, 2008.
25.
Lopez-TorresM, Perez-CampoR, RojasC, Barja de and QuirogaC. Sensitivity to in vitro lipid peroxidation in liver and brain of aged rats. Rev Esp Fisiol, 48: 191–196, 1992.
MatheuA, MaraverA, KlattP, FloresI, Garcia-CaoI, BorrasC, FloresJM, VinaJ, BlascoMA, and SerranoM. Delayed ageing through damage protection by the Arf/p53 pathway. Nature, 448: 375–379, 2007.
28.
MerzCN, JohnsonBD, BergaSL, BraunsteinGD, AzzizR, YangY, ReisSE, BittnerV, HodgsonTK, PepineCJ, SharafBL, SopkoG, and KelseySF. Total estrogen time and obstructive coronary disease in women: insights from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE). J Womens Health (Larchmt), 18: 1315–1322, 2009.
29.
MillerVM, BlackDM, BrintonEA, BudoffMJ, CedarsMI, HodisHN, LoboRA, MansonJE, MerriamGR, NaftolinF, SantoroN, TaylorHS, and HarmanSM. Using basic science to design a clinical trial: baseline characteristics of women enrolled in the Kronos Early Estrogen Prevention Study (KEEPS). J Cardiovasc Transl Res, 2: 228–239, 2009.
30.
MoranJ, GarridoP, AlonsoA, CabelloE, and GonzalezC. 17beta-Estradiol and genistein acute treatments improve some cerebral cortex homeostasis aspects deteriorated by aging in female rats. Exp Gerontol, 48: 414–421, 2013.
31.
NevoO, SoustielJF, and ThalerI. Cerebral blood flow is increased during controlled ovarian stimulation. Am J Physiol Heart Circ Physiol, 293: H3265–H3269, 2007.
32.
OchsH, DusterbergB, GunzelP, and Schulte-HermannR. Effect of tumor promoting contraceptive steroids on growth and drug metabolizing enzymes in rat liver. Cancer Res, 46: 1224–1232, 1986.
33.
ResnickSM and HendersonVW. Hormone therapy and risk of Alzheimer disease: a critical time. JAMA, 288: 2170–2172, 2002.
34.
ResnickSM, MakiPM, RappSR, EspelandMA, BrunnerR, CokerLH, GranekIA, HoganP, OckeneJK, and ShumakerSA. Effects of combination estrogen plus progestin hormone treatment on cognition and affect. J Clin Endocrinol Metab, 91: 1802–1810, 2006.
35.
RickwoodR, WilsonMT, and Darley-UsmarVM. Isolation and characteristics of intact mitochondria. In: Mitochondria, a Practical Approach, edited by RickwoodR, WilsonMT, and Darley-UsmarVM. Reino Unido: IRL Press, Ltd., 1987, pp. 1–16.
36.
RistowM and SchmeisserS. Extending life span by increasing oxidative stress. Free Radic Biol Med, 51: 327–336, 2011.
37.
RosanoGM, VitaleC, SilvestriA, and FiniM. Hormone replacement therapy and cardioprotection: the end of the tale?. Ann N Y Acad Sci, 997: 351–357, 2003.
38.
RossouwJE, AndersonGL, PrenticeRL, LaCroixAZ, KooperbergC, StefanickML, JacksonRD, BeresfordSA, HowardBV, JohnsonKC, KotchenJM, and OckeneJ. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA, 288: 321–333, 2002.
39.
Ruiz-LarreaMB, LealAM, MartinC, MartinezR, and LacortM. Antioxidant action of estrogens in rat hepatocytes. Rev Esp Fisiol, 53: 225–229, 1997.
40.
SastreJ, BorrasC, Garcia-SalaD, LloretA, PallardoFV, and VinaJ. Mitochondrial damage in aging and apoptosis. Ann N Y Acad Sci, 959: 448–451, 2002.
41.
SastreJ, PallardoFV, PlaR, PellinA, JuanG, O'ConnorJE, EstrelaJM, MiquelJ, and VinaJ. Aging of the liver: age-associated mitochondrial damage in intact hepatocytes. Hepatology, 24: 1199–1205, 1996.
42.
SchierbeckLL, RejnmarkL, ToftengCL, StilgrenL, EikenP, MosekildeL, KoberL, and JensenJE. Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial. BMJ, 345: e6409, 2012.
43.
SherwinBB. The critical period hypothesis: can it explain discrepancies in the oestrogen-cognition literature?. J Neuroendocrinol, 19: 77–81, 2007.
44.
ShumakerSA, LegaultC, KullerL, RappSR, ThalL, LaneDS, FillitH, StefanickML, HendrixSL, LewisCE, MasakiK, and CokerLH. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. JAMA, 291: 2947–2958, 2004.
45.
SpencerC, CrookD, RossD, CooperA, WhiteheadM, and StevensonJ. A randomised comparison of the effects of oral versus transdermal 17beta-oestradiol, each combined with sequential oral norethisterone acetate, on serum lipoprotein levels. Br J Obstet Gynaecol, 106: 948–953, 1999.
46.
VinaJ and BorrasC. Women live longer than men: understanding molecular mechanisms offers opportunities to intervene by using estrogenic compounds. Antioxid Redox Signal, 13: 269–278, 2010.
47.
VinaJ, BorrasC, GambiniJ, SastreJ, and PallardoFV. Why females live longer than males? Importance of the upregulation of longevity-associated genes by oestrogenic compounds. FEBS Lett, 579: 2541–2545, 2005.
48.
ViñaJ. A Free radical theory of ageing revisted. In: SFRR-Europe 2011 Meeting. Redox Biology and Micronutrients: From Singaling to Translation and Back. Istambul, 2011.
49.
WongSH, KnightJA, HopferSM, ZahariaO, LeachCNJr., and SundermanFW, Jr. Lipoperoxides in plasma as measured by liquid-chromatographic separation of malondialdehyde-thiobarbituric acid adduct. Clin Chem, 33: 214–220, 1987.
50.
ZhuC, ZhangL, ZhengY, XuJ, SongJ, RolfeBE, and CampbellJH. Effects of estrogen on stress-induced premature senescence of vascular smooth muscle cells: a novel mechanism for the “time window theory” of menopausal hormone therapy. Atherosclerosis, 215: 294–300, 2011.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
